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Summary
We examined the effects of gestational cocaine treatment on oxytocin levels in the whole
hippocampus (HIP), ventral tegmental area (VTA), medial preoptic area (MPOA) and amygdala
(AMY) in rat dams on postpartum days (PPDs) 1 and 2. Cocaine treatment significantly reduced
oxytocin levels in the MPOA within 12–16 h of delivery (PPD 1), but had no significant effect on
the other brain areas. Oxytocin was significantly reduced in the HIP and VTA but not in the AMY
or MPOA on PPD 2. These data provide the first evidence for the reduction of oxytocin levels in
the VTA, HIP and MPOA as a result of gestational cocaine treatment.
INTRODUCTION
When centrally administered, the neuropeptide oxytocin (OXY) rapidly induces specific
species typical components of maternal behavior in rats such as nest building, pup retrieval
and grouping, cleaning and licking of pups and crouching over pups in a nursing posture.1-3
Intracerebroventricular (i.c.v.) infusions of oxytocin antagonists or antiserum block or delay
the onset of maternal behavior of parturient rats.4-6 It has also been shown that oxytocin
infused into the central nucleus of the amygdala of hamsters markedly increases postpartum
aggression.7 All of these reports support the hypothesis that the onset of maternal behavior,
and subsequently maternal aggression, is at least partially regulated by oxytocin.
We and others,8-10 have reported that, when given throughout gestation, cocaine, a
commonly abused drug,11 and dopamine and serotonin reuptake inhibitor,12 delays the
initial activation of maternal behavior of rat dams and increases maternal aggression8,13
towards a male or female intruder.
We have hypothesized that cocaine, acting through dopaminergic and/or serotonergic
systems, alters oxytocin neurotransmission, which in turn affects maternal behavior and
maternal aggression.8,14 Oxytocin levels were found to be significantly reduced in the
amygdala (AMY) of the aggressive cocaine-treated rat dams at 8 days postpartum.15
Conversely, elevated oxytocin levels were found in the AMYs of acutely treated
unaggressive rat dams on postpartum days (PPDs) 6 and 10.16 These data support our
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hypothesis that cocaine is affecting at least one aspect of maternal behavior (aggression)
through alterations of the oxytocinergic system in the AMY, a brain area thought to be
involved in maternal aggressive behavior.7,8,15,16
Most recently, oxytocin has been shown to play a critical role in postpartum activation of
maternal behavior in the ventral tegmental area (VTA) and medial preoptic area (MPOA).17
These brain areas, as well as the hippocampus (HIP), contain oxytocinergic, dopaminergic
and/or serotonergic receptors, neurons or pathways, which have been strongly implicated in
the regulation of maternal behavior.15,18-20
In the present study we assessed the effects of chronic gestational cocaine treatment on
oxytocin levels in the AMY, MPOA, VTA and HIP on PPDsl and 2, a time when oxytocin is




Gravid, nulliparous Sprague-Dawley rats (Charles River, Raleigh, NC) (250–275 g) received
subcutaneous (s.c.) injections, twice daily at approximately 08:00 and 16:00 throughout
gestation (gestation days [GDs] 1–20), normal saline (0.9%), or 15 mg/kg cocaine
hydrochloride (HCL; Sigma, St Louis, MO) dissolved in normal saline. Rats were randomly
assigned to the treatment groups or as a surrogate (no treatment) the morning a sperm plug
was found (GD 0). Dams were housed singly on a 12:12-h reversed light–dark cycle with
lights out at 09:00. Treatment and surrogate dams all had free access to food (rat chow) and
water. Daily weight gain was measured for treatment subjects. Immediately following
completion of delivery, the litter weight, pup sizes and number were recorded, and the
natural litters were given to a surrogate. Each treatment dam was then given 4 surrogate
pups (2 of each sex) born within 12–24 h of her own delivery. At approximately 09:00 on
the first morning (PPD 1) following delivery (delivery generally occurred between 15:00
and 18:00, half the subjects in each treatment group were killed by decapitation. This
procedure was repeated with the remaining subjects from both treatment groups on the
second morning following delivery (PPD 2), also at 09:00. Immediately after decapitation,
the whole HIP, MPOA, AMY and VTA of each subject were dissected out on ice, weighed,
rapidly frozen and stored at −70°C for later radioimmunoassay. Procedures involving
animals and their care were approved by, and conducted in conformity with, the institutional
guidelines, which are in compliance with national and international laws and policies (NIH
guide for the care and use of laboratory animals, NIH publication no. 85-23, 1985).
University veterinarians supervised the care and use of these animals and no unhealthy
animals were employed in this study.
Dissection
Briefly, brains were coronally sectioned from the ventral side rostral to the optic chiasm
[approximately A 7100 μm according to Konig & Klippel22] and just caudal to the optic
chiasm (approximately A 5800 μm) to define the preoptic-anterior hypothalamic area.
Vertical cuts ventral from the lines of the lateral ventricles and a horizontal slice through the
anterior commissure were made to produce a block section of the MPOA. Brains were
sectioned once again just caudal to the tuber cinereum (approximately A 3800 μm) and
slightly above the cerebellum, and the AMY was removed in this section. The whole HIP
was then removed from the caudal remainder of the brain, and the VTA was dissected from
this portion by making dorsoventral cuts medial to the optic tracts with a dorsal cut at the
ventral extent of the central gray.
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Brain tissues were homogenized in cold buffer (19 mM monobasic sodium phosphate, 81
mM dibasic sodium phosphate, 0.05 M NaCl, 0.1% BSA, 0.1% Triton × 100, 0.1 % sodium
oxide at pH 7.4) and centrifuged at 3000 × g for 30 min. Supernatants were analyzed for
OXY immunoreactive content according to a protocol from Peninsula Laboratories, Inc.
(Belmont, CA) for each brain area/animal. All supplies were obtained from Peninsula Labs.
Briefly, oxytocin-like immunoreactivity was assayed by incubating samples and standards
(0.5–500 pg) in duplicate for 16–24 h at 0°C, with rabbit anti-oxytocin serum (Peninsula
Lab, Belmont, CA, lot 023204-2) at a final dilution of 1:39 000. The assay samples and
standards were then incubated with 125 I-oxytocin (specific activity 1286 Ci/mmol) for 16–
24 h at 0°C. The bound oxytocin was separated from free by incubating with normal rabbit
serum and goat anti-rabbit IgG serum and centrifugation for 40 min at 2500 rpm.
Radioactivity was measured by an LKB Clinigamma counter which estimates B/Bo from the
standard curve and estimates pg amounts from that determination for each sample. Cross-
reactivity of arginine vasopressin and somatostatin was undetectable. The sensitivity of the
assay was 13 pg/tube. An intra-assay coefficient of variation (CV) of <5% and an inter-assay
CV of <14% at approximately 50% binding were determined. Oxytocin levels were
analyzed by analyses of variance (ANOVA) followed by post-hoc tests comparing pg/mg
wet tissue weight between groups on PPDs 1 and 2.
RESULTS
There were no significant differences between treatment groups in gestational weight gain,
number of live pups, grams per pup or days of gestation (Table).
Gestational cocaine treatment significantly reduced oxytocin levels (pg/mg) in the medial
preoptic area on PPD 1, (F(1, 14) = 4.59, P < 0.05, Figure) compared with saline-treated
animals. Oxytocin levels in the VTA, HIP and AMY were not significantly different
between groups, although cocaine treatment resulted in slightly lower levels of oxytocin in
the ventral tegmental area. On PPD 2, oxytocin levels were significantly reduced in the VTA
(F (1, 17) = 5.96, P < 0.03) and HIP (F (1, 18) = 9.87, P < 0.01) of cocaine-treated dams
compared with saline-treated dams. Oxytocin levels were reduced, though not quite
significantly, in the MPOA of cocaine-treated dams and there was no difference between
cocaine- and saline-treated dams, on oxytocin levels in the AMY (Figure).
DISCUSSION
We have demonstrated that chronic gestational cocaine treatment reduces oxytocin in brain
sites thought to play a critical role in the initiation of maternal behavior at a time when
oxytocin is thought to have a substantial impact on those behaviors. This is the first report
showing that cocaine treatment reduces oxytocin in the MPOA, HIP and VTA at about the
same time that early postpartum maternal behavior is altered by this same dose of cocaine
(30 mg/kg). That gestational cocaine treatment did not reduce oxytocin in the AMY during
this early postpartum period is consistent with the behavioral data. During the first 12–17 h
following parturition, rat dams normally experience postpartum estrus and are usually not as
aggressive towards a male intruder as they are during PPDs 3–12. We have previously
reported that chronic gestational cocaine treatment, using the same dose and regimen that
was employed in this study, both increased aggression towards an intruder and reduced
oxytocin in the AMY on PPD 8.15 Recent studies16,23 have determined that acute, unlike
chronic, cocaine treatment reduces postpartum maternal aggression. In one of these
studies,16 oxytocin levels were significantly elevated in the AMY of the least aggressive rat
dams. These correlational data support our hypodiesis that cocaine treatment alters maternal
Johns et al. Page 3













behavior at least partially through its effects on the oxytocin system. These results, taken
together, suggest that oxytocin is involved in alterations of maternal aggression.
Several studies,14,24 have previously reported that acute and repeated cocaine treatment
reduces oxytocin in the HIP of non-pregnant rats. Lesions of the dorsal HIP in postpartum
rats have been shown to significandy disrupt maternal behaviors such as crouching, nest
building and grouping of pups.19 We have reported that both crouching and nest building are
disrupted or delayed in rat dams treated throughout gestation with cocaine.8 We have not, as
yet, found a reduction in oxytocin levels in the HIP on PPDs 8 or 10 as a result of either
acute postpartum or chronic gestational cocaine treatment at the time when maternal
aggression is altered by cocaine. These findings suggest that the HIP may not be as
important a site as the AMY in the regulation of maternal aggression. The present findings
suggest that if behaviors are affected by the reduction of oxytocin in the HIP of cocaine-
treated dams, they are more likely to be the initial onset of pup-directed maternal behaviors.
It has been suggested that a pathway that leads from the MPOA to the VTA, which appears
to be critical for the expression of maternal behavior, may be oxytocinergic.25,26 It has also
been determined that oxytocin antagonists infused into the VTA and oxytocin and VI
antagonists infused into the MPOA block the initiation of maternal behavior.17 Oxytocin
binding is also higher in both these brain areas during mid-parturition compared with other
pre- (GDs 15–17) and postpartum (PPDs 5–7) time periods.17 Although we have not
examined oxytocin levels in the MPOA other than on PPDs 1 and 2, we have found no
cocaine-induced reductions (acute or chronic) in the VTA from PPDs 6–10. We have
reported slight elevations of oxytocin in the VTA following acute cocaine treatment of
ovariectomized, estrogen-treated rats.4
While it is not yet clear where the oxytocin neurons that project to the MPOA and VTA lie,
the dorsolateral preoptic area, rostral paraventricular nucleus and anterior commissural
nucleus have been implicated.27 We have previously suggested a possible neurochemical
pathway by which cocaine may be interacting with the oxytocinergic system.8,14 The
ascending mesolimbic dopaminergic system (A10), which originates in the VTA, projects to
both the HIP and the AMY.28 Receptors that bind oxytocin, dopamine or cocaine are found
in several brain structures of the limbic system including the VTA, HIP and AMY.20,28-31
Cocaine, a dopaminergic (as well as serotonergic and noradrenergic) reuptake inhibitor, may
alter oxytocin levels indirectly via its actions on the dopaminergic system in the VTA32,33
Manipulations of the dopaminergic system have been reported to alter some of the same
behaviors that are altered by both cocaine and oxytocin.34,35 However, since gestational
cocaine treatment alters maternal behavior and only slightly increases locomotor and
stereotyped behaviors, the dopaminergic system is probably not the only neurotransmitter
system implicated in the effects of cocaine on maternal behavior.
The present findings provide further support for a cocaine–oxytocin interaction which
appears to be mediated, in some part, through oxytocin levels being altered in structures
(VTA, HIP) that are a part of the dopaminergic mesolimbic pathway. Changes in oxytocin
levels first appear in the MPOA, then soon afterward in the VTA and HIP. It is not yet clear
how the MPOA fits into the overall scheme, but determination of the location of the
oxytocin neurons projecting to the MPOA should be helpful. Cocaine could be acting
directly on oxytocin neurons in the MPOA or acting through dopamine receptors which alter
oxytocin levels. There are also both dopaminergic and noradrenergic projections from the
VTA to the MPOA, through which cocaine could have a secondary affect on oxytocin
release.36
Johns et al. Page 4













We are not suggesting that oxytocin is the only important neurochemical that might be
involved in the cocaine-induced disruption of maternal behavior. A vasopressin (VI)
antagonist infused into the MPOA has been shown to block maternal behavior.17 The effect
of gestational cocaine treatment on vasopressin has not, to our knowledge, been elucidated.
Others have reported that opioids infused into the MPOA can inhibit maternal behavior.37
Prolactin, which is normally under tonic inhibition by dopamine, could also be altered by
cocaine treatment and thereby alter some aspects of maternal behavior.38 All of these
possibilities require further investigation.
Future experiments will include the examination of cocaine-related changes in oxytocin,
dopamine and serotonin receptor binding in these, and perhaps other, brain structures. We
hope to determine soon if an oxytocin antagonist infused into the amygdala on PPDs 6–10
alters maternal aggression as does cocaine. It will also be important to determine through
which neurotransmitter systems cocaine exerts its effects to alter oxytocin levels and/or
receptors. These findings have implications for our understanding of how cocaine and
oxytocin interact at a time when oxytocin appears to be necessary for the initiation of normal
maternal behavior.
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(A) The effect of chronic cocaine on mean levels of oxytocin (p/mg) in the AMY, VTA, HIP
and MPOA on PPD 1. There were no significant differences between saline (n = 8) and
cocaine (n = 8) treatment groups in the AMY (P < 0.86), HIP (P < 0.84) or VTA (P < 0.94;
n = 7 cocaine, n = 8 saline). Levels of oxytocin were significantly reduced In the MPOA of
the cocaine (n = 8 per group)-treated females (0.64 ± 0.06) compared with saline-treated
females (0.82 ± 0.06; * P < 0.05, ANOVA). (B) The effect of chronic cocaine on mean
levels of oxytocin (p/mg) in the AMY, VTA, MPOA and HIP on PPD2. There were no
significant differences between saline (n = 9) and cocaine (n = 11) treatment groups in the
amygdala (P < 0.93) or MPOA (P < 0.24). Levels of oxytocin were significantly reduced in
the HIP (0.27 ± 0.01) and VTA (0.75 ± 0.24) of cocaine-treated females, compared with
saline-treated females ([0.32 ± 0.01) HIP, *P < 0.01; [1.59 ± 0.25] VTA, **P < 0.03,
(ANOVA).
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